Author:
Kloiber Stefan,Konstantinou Gerasimos
Publisher
Springer International Publishing
Reference74 articles.
1. Ahmed S, Stanciu CN, Kotapati PV, Ahmed R, Bhivandkar S, Khan AM, et al. Effectiveness of gabapentin in reducing cravings and withdrawal in alcohol use disorder: a meta-analytic review. Prim Care Companion CNS Disord. 2019;21(4):19r02465.
2. Aquin JP, El-Gabalawy R, Sala T, Sareen J. Anxiety disorders and general medical conditions: current research and future directions. Focus (Am Psychiatr Publ). 2017;15(2):173–81.
3. Arbex MA, Varella Mde C, Siqueira HR, Mello FA. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs. J Bras Pneumol. 2010a;36(5):641–56.
4. Arbex MA, Varella MCL, Siqueira HR, Mello FAF. Drogas antituberculose: interações medicamentosas, efeitos adversos e utilização em situações especiais – parte 2: fármacos de segunda linha. J Bras Pneumol. 2010b;36:641–56.
5. Arunogiri S, Lubman DI. Anxiety and substance use disorders: a worrying combination. Australas Psychiatry. 2015;23(4):382–7.